Skip to main content
SpringerLink
Log in

Reply to the letter of Junginger et al. Strahlenther Onkol 2013 DOI 10.1007/s00066-013-0353-y

Antwort auf den Brief von Junginger et al. Strahlenther Onkol 2013 DOI 10.1007/s00066-013-0353-y

  • Letter to the editor
  • Published:
Strahlentherapie und Onkologie Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Bernstein TE, Endreseth BH, Romundstad P, on behalf of the Norwegian Colorectal Cancer Registry et al (2012) Improved local control of rectal cancer reduces distant metastases. Colorectal Dis 14:e668–e678

    Article  PubMed  CAS  Google Scholar 

  2. Birgisson H, Pahlman L, Gunnarsson U et al (2005) Adverse effects of preoperative radiation therapy for rectal cancer: long-term follow-up the Swedish Rectal Cancer Trial. J Clin Oncol 23:8697–8705

    Article  PubMed  Google Scholar 

  3. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355(11):1114–1123

    Article  PubMed  CAS  Google Scholar 

  4. Bujko K, Nowacki MP, Masierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215–1223

    Article  PubMed  CAS  Google Scholar 

  5. Eriksen MT, Wibe A, Haffner J et al (2006) Prognostic groups in 1,676 patients with T3 rectal cancer treated without preoperative radiotherapy. Dis Colon Rectum 50:157–167

    Google Scholar 

  6. Fleming FJ, Pahlman L, Monson JR (2011) Neoadjuvant therapy in rectal cancer. Dis Colon Rectum 54:901–912

    Article  PubMed  Google Scholar 

  7. Frasson M, Garcia-Granero E, Roda D et al (2011) Preoperative chemoradiation may not always be needed for patients with T3 and T2N + rectal cancer. Cancer 177:3118–3125

    Article  Google Scholar 

  8. Gunderson LL, Sargent DJ, Tepper JE et al (2004) Impact of T and N stage and treatmend on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22:1785–1796

    Article  PubMed  Google Scholar 

  9. Ligue Nationale contre le Cancer (2006) Therapeutic choices for rectal cancer. Gastroenterol Clin Biol 30:59–69

    Article  Google Scholar 

  10. Maurer CA, Mattiello D, Duwe J et al (2012) Oncological short-term effects and adverse events of MRI-guided selective neoadjuvant radiochemotherapy for rectal cancer. Anticancer Res 32:1721–1728

    PubMed  CAS  Google Scholar 

  11. Nagtegaal ID, Quirke P (2008) What is the role for the cicumferential margin in the modern treatment of rectal cancer? J Clin Oncol 26:303–312

    Article  PubMed  Google Scholar 

  12. Potts M, Prata N, Walsh J et al (2006) Parachute approach to evidence based medicine. BMJ 333:701–703

    Article  PubMed  Google Scholar 

  13. Quirke P, Steele R, Monson J et al (2009) Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG C016 randomised clinical trial. Lancet 373:821–828

    Article  PubMed  Google Scholar 

  14. Reeves BC (2006) Parachute approach to evidence based medicine: as obvious as ABC. BMJ 333:807

    Article  PubMed  Google Scholar 

  15. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731–1740

    Article  PubMed  CAS  Google Scholar 

  16. Sauer R, Liersch T, Merkel S et al (2012) Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years. J Clin Oncol 30:1926–1933

    Article  PubMed  CAS  Google Scholar 

  17. Sautter-Bihl ML, Hohenberger W, Fietkau R (2013) Rectal cancer: when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol 189 105–110

    Google Scholar 

  18. Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811–820

    Article  PubMed  Google Scholar 

  19. Simunovic M, Sexton R, Rempel E et al (2003) Optimal preoperative assessment and surgery for rectal cancer may greatly limit the need for radiotherapy. Br J Surg 90:999–1003

    Article  PubMed  CAS  Google Scholar 

  20. Simunovic M, Jacob S, Coates AJ et al (2011) Outcomes following a limited approach to radiotherapy in rectal cancer. Br J Surg 98:1483–1488

    Article  PubMed  CAS  Google Scholar 

  21. Strassburg J, Ruppert R, Ptok H (2011) MRI-based indications for neoadjuvant radiochemotherapy in rectal carcinoma: interim results of a prospective multicenter observational study. Ann Surg Oncol 18:2790–2799

    Article  PubMed  Google Scholar 

  22. Taylor F, Quirke P, Heald RJ et al (2011) Preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone. Ann Surg 253:711–719

    Article  PubMed  Google Scholar 

  23. Ulrich A, Weitz J, Büchler MW (2009) Rectal cancer. How much radiotherapy do surgery patients need? Chirurg 80:266–273

    Article  PubMed  CAS  Google Scholar 

  24. Van Gijn W, Marijnen AM, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575–582

    Article  Google Scholar 

Download references

Conflict of interest

On behalf of all authors, the corresponding author states that there are no conflicts of interest.

Author information

Authors and Affiliations

  1. Klinik für Radioonkologie und Strahlentherapie, Städtisches Klinikum Karlsruhe, Moltkestr. 90, 76133, Karlsruhe, Germany

    M.L. Sautter-Bihl

  2. Chirurgische Klinik, Universitätsklinikum Erlangen, Erlangen, Germany

    W. Hohenberger

  3. Strahlenklinik, Universitätsklinikum Erlangen, Erlangen, Germany

    R. Fietkau & R. Sauer

  4. Klinik für Strahlentherapie, Klinikum der Johann Wolfgang Goethe-Universität Frankfurt, Frankfurt, Germany

    C. Rödel

  5. Klinik und Poliklinik für Radioonkologie und Strahlentherapie, Klinik der Johann Gutenberg Universität Mainz, Mainz, Germany

    H. Schmidberger

Authors
  1. M.L. Sautter-Bihl
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. W. Hohenberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. R. Fietkau
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C. Rödel
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. H. Schmidberger
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. R. Sauer
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sautter-Bihl, M., Hohenberger, W., Fietkau, R. et al. Reply to the letter of Junginger et al. Strahlenther Onkol 2013 DOI 10.1007/s00066-013-0353-y. Strahlenther Onkol 189, 700–701 (2013). https://doi.org/10.1007/s00066-013-0406-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00066-013-0406-2

Keywords

Search

Navigation